Table 3. Determination of COX-2 and PPARγ proteins in ovarian tumours.
Tissue | Case | Amount of COX-2 protein (ng per mg protein) | Amount of PPARγ protein (μg (cell extract)−1 (well)−1) |
---|---|---|---|
Benign cystadenoma | 1 | ND | ND |
2 | ND | ND | |
3 | ND | ND | |
4 | ND | ND | |
Borderline tumour | 1 | ND | 92.9 |
2 | ND | 74.7 | |
3 | ND | 57.9 | |
Carcinoma | 1 | 3.91 | ND |
2 | 3.69 | ND | |
3 | 2.65 | ND | |
4 | 2.32 | ND | |
5 | 2.22 | ND | |
6 | 1.98 | ND | |
7 | 1.72 | ND | |
8 | 1.25 | ND | |
9 | ND | ND | |
10 | ND | ND | |
11 | ND | 70.1 | |
12 | ND | 60.2 |
ND stands for not detectable.